Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ACTINIUM PHARMACEUTICALS, INC.

(ATNM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société ACTINIUM PHARMACEUTICALS, INC.
10/04ACTINIUM PHARMACEUTICALS : Announces Two Abstracts Highlighting Combinations of CD47 Targe..
AQ
09/29ACTINIUM PHARMACEUTICALS : to Present at the Cantor Fitzgerald Virtual Global Healthcare C..
AQ
09/29ACTINIUM PHARMACEUTICALS RALLY TAKES : Atnm)
AQ
09/28ACTINIUM PHARMACEUTICALS : Announces Expansion of R&D Team and Facilities to Accelerate Re..
AQ
09/23ACTINIUM PHARMACEUTICALS : Announces Multiple Senior Leadership Appointments Including Chi..
PU
09/23ACTINIUM PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Regulation FD ..
AQ
09/23ACTINIUM PHARMACEUTICALS RALLY INTAC : Atnm)
AQ
09/21ACTINIUM PHARMACEUTICALS STOCK JUMPS : Atnm)
AQ
09/16ACTINIUM PHARMACEUTICALS : Completes Enrollment in the Pivotal Phase 3 SIERRA Trial of Iom..
AQ
07/30ACTINIUM PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
06/29ACTINIUM PHARMACEUTICALS : Announces Inclusion in Russell Microcap Index
AQ
06/04ACTINIUM PHARMACEUTICALS : Announces Several Presentations from the Phase 3 SIERRA Study o..
AQ
05/14ACTINIUM : Q1 Earnings Snapshot
AQ
05/14ACTINIUM PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
04/01ACTINIUM PHARMACEUTICALS : to Participate in the Cell & Gene Meeting on the Mediterranean
AQ
03/31ACTINIUM PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
03/26ACTINIUM PHARMACEUTICALS : Announces Completion of Enrollment of Second Dose Cohort in Act..
AQ
03/25ACTINIUM PHARMACEUTICALS : Announces Initiation of Patient Enrollment in Iomab-ACT Trial f..
AQ
03/12ACTINIUM PHARMACEUTICALS : to Highlight Expansion of Targeted Conditioning Portfolio at AA..
AQ
03/04ACTINIUM PHARMACEUTICALS : Announces Appointment of Mark Kubik, MBA as Chief Business Offi..
AQ
03/03ACTINIUM PHARMACEUTICALS : Announces Participation in H.C. Wainwright Global Life Sciences..
AQ
02/11ACTINIUM PHARMACEUTICALS : Safety Results with Targeted Conditioning via Iomab-B
PU
02/11ACTINIUM PHARMACEUTICALS : Announces Participation in BIO CEO and Investor Digital Confere..
AQ
01/21ACTINIUM PHARMACEUTICALS : to Participate in a Fireside Chat at the B. Riley Oncology Inve..
AQ
01/14ACTINIUM PHARMACEUTICALS : and Astellas Announce Research Collaboration Focused on Novel -..
AQ
2020ACTINIUM PHARMACEUTICALS : Announces Successful Pre-Planned Ad Hoc Interim Analysis of Pha..
AQ
2020ACTINIUM PHARMACEUTICALS : Highlights Presence at Targeted Radiopharmaceuticals Summit
AQ
2020ACTINIUM PHARMACEUTICALS : Reports 67 Percent Overall Response Rate in First Cohort in Act..
AQ
2020ACTINIUM PHARMACEUTICALS : Highlights Clinical Data to be presented at the Upcoming 62nd A..
AQ
2020ACTINIUM PHARMACEUTICALS : Appoints Mary Mei Chen, M.D., Ph.D. as Vice President of Clinic..
AQ
2020ACTINIUM PHARMACEUTICALS : Highlights Foundational Patents Covering the Composition of Apa..
AQ
2020ACTINIUM PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Submission of ..
AQ
2020ACTINIUM PHARMACEUTICALS : Strengthens Leadership Team with Appointment of Dr. Avinash Des..
AQ
2020ACTINIUM PHARMACEUTICALS : to Participate in the Alliance Global Partners Virtual Healthca..
AQ
2020ACTINIUM PHARMACEUTICALS : Investor Presentation
PU
2020ACTINIUM PHARMACEUTICALS : Letter to Shareholders
PU
2020ACTINIUM PHARMACEUTICALS : Provides Corporate Update and Year-End 2020 Outlook
AQ
2020ACTINIUM PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhibi..
AQ
2020ACTINIUM PHARMACEUTICALS : Investor Presentation
PU
2020ACTINIUM PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
2020ACTINIUM PHARMACEUTICALS : Investor Presentation
PU
2020ACTINIUM PHARMACEUTICALS : Awarded Grant by National Institutes of Health to Study Novel I..
AQ
2020ACTINIUM PHARMACEUTICALS : Expands R&D Capabilities with New Research Facility to Enhance ..
AQ
2020ACTINIUM PHARMACEUTICALS : Successfully Completes First Dosing Cohort in the Phase 1 Study..
AQ
2020ACTINIUM PHARMACEUTICALS : Announces Successful Completion of Planned Phase 1 Actimab-A CL..
AQ
2020ACTINIUM PHARMACEUTICALS : Investor Presentation
PU
2020ACTINIUM PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
2020ACTINIUM PHARMACEUTICALS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fisca..
AQ
2020ACTINIUM PHARMACEUTICALS : Announces Reverse Stock Split
AQ
2020ACTINIUM PHARMACEUTICALS, INC. : Other Events (form 8-K)
AQ
2020ACTINIUM PHARMACEUTICALS, INC. : Other Events (form 8-K)
AQ
2020ACTINIUM PHARMACEUTICALS : Investor Presentation
PU
2020ACTINIUM PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
2020ACTINIUM PHARMACEUTICALS : Announces Closing of $25.0 Million Public Offering
AQ
2020ACTINIUM PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K..
AQ
2020ACTINIUM PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Other Events,..
AQ
2020ACTINIUM PHARMACEUTICALS : Announces Proposed Public Offering
AQ
2020ACTINIUM PHARMACEUTICALS : Announces Pricing of $25.0 Million Public Offering
AQ
2020ACTINIUM PHARMACEUTICALS, INC. : Other Events (form 8-K)
AQ
2020ACTINIUM PHARMACEUTICALS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fisca..
AQ
2020ACTINIUM PHARMACEUTICALS, INC. : Other Events (form 8-K)
AQ
2020ACTINIUM PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
2020ACTINIUM PHARMACEUTICALS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fisca..
AQ
2020ACTINIUM PHARMACEUTICALS, INC. : Notice of Delisting or Failure to Satisfy a Continued Lis..
AQ
2020ACTINIUM PHARMACEUTICALS : Announces Closing of $31.6 Million Public Offering, including F..
AQ
2020ACTINIUM PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Financial Sta..
AQ
2020ACTINIUM PHARMACEUTICALS : Announces Proposed Public Offering
AQ
2020ACTINIUM PHARMACEUTICALS, INC. : Other Events (form 8-K)
AQ
2020ACTINIUM PHARMACEUTICALS : Announces First Patient Treated in Third and Final Dose Cohort ..
AQ
2020ACTINIUM PHARMACEUTICALS : Feasibility of Administering Iomab-B without Lead-Lined Rooms
PU
2020ACTINIUM PHARMACEUTICALS : Investor Presentation
PU
2020ACTINIUM PHARMACEUTICALS : Announces Actimab-A Plus 7+3 Combination trial for Newly Diagno..
AQ
2020ACTINIUM PHARMACEUTICALS : Mid-Point Analysis of Pivotal Phase 3 SIERRA Trial Including Ma..
PU
2020ACTINIUM PHARMACEUTICALS : to Highlight Targeted Conditioning Portfolio at 2020 Transplant..
AQ
2020ACTINIUM PHARMACEUTICALS INC. : to Present at the 22nd Annual BIO CEO & Investor Conferenc..
AQ
1  2  3  4Next
Upcoming event on ACTINIUM PHARMACEUTICALS, INC.
11/12/21